StockData

Goldenwell Biotech, Inc. (GWLL) stock

GWLLOTCFood and Kindred ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.65+0.05 (+8.33%)

Close on Oct 19, 2026Market cap $64.35MP/E –Yield –

Goldenwell Biotech operating margin

Operating margin is operating income as a percentage of revenue.

Goldenwell Biotech's operating margin for the twelve months ending Jun 30, 2026 was -208729.1%. For fiscal 2025 it was -206047.3%, against -88559.7% the year before. The highest annual figure on record is -740.7% in fiscal 2021.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-206047.3%−117487.6
FY2024Dec 31, 2024-88559.7%−82251.1
FY2023Dec 31, 2023-6308.6%−4247.7
FY2022Dec 31, 2022-2060.9%−1320.2
FY2021Dec 31, 2021-740.7%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2025Dec 31, 2025-41627.3%−31814.2
Q2 FY2024Jun 30, 2024-34402.9%−32039.6
Q4 FY2023Dec 31, 2023-7999.6%−7989.1
Q3 FY2023Sep 30, 2023-9268.6%−8546.8
Q2 FY2023Jun 30, 2023-9813.0%−1403.2
Q1 FY2023Mar 31, 2023-2363.3%−320.2
Q3 FY2022Sep 30, 2022-10.5%+718.7
Q2 FY2022Jun 30, 2022-721.8%–
Q1 FY2022Mar 31, 2022-8409.8%–
Q4 FY2021Dec 31, 2021-2043.1%–
Q3 FY2021Sep 30, 2021-729.2%–

More Goldenwell Biotech figures

See a number that looks wrong?